Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.

Archives of medical research - 1 Jan 2020

Zakharyan Roksana, Ghazaryan Hovsep, Kocourkova Lenka, Chavushyan Andranik, Mkrtchyan Artur, Zizkova Veronika, Arakelyan Arsen, Petrek Martin

Abstract excerpt

BACKGROUND: Several studies indicated that antipsychotic treatment response and side effect manifestation can be different due to inter-individual variability in genetic variations. AIM OF THE STUDY: Here we perform a case-control study to explore a potential association between schizophrenia and variants within the antipsychotic drug molecular targets (DRD1, DRD2, DRD3, HTR2A, HTR6) and metabolizing enzymes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Catechol O-Methyltransferase

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2D6

Share to Dopamine

Share to Metabolic Networks and Pathways

Share to Receptors, Dopamine

Share to Receptors, Serotonin

Share to Serotonin

Source

Identifiers

PMID: 32086104
DOI: 10.1016/j.arcmed.2019.12.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.PMID 32086104Read ↗

Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia.Semantic proximity Read ↗

Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.Semantic proximity Read ↗

Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.Semantic proximity Read ↗

Exploring pharmacogenetic variation in a Bulgarian psychiatric cohort.Semantic proximity Read ↗

Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphismsSemantic proximity Read ↗

GENETIC VARIANTS IN ANTIPSYCHOTIC METABOLISM: POLYMORPHISM PROFILES IN KAZAKH COHORT WITH PARANOID SCHIZOPHRENIA.Semantic proximity Read ↗

Investigating DRD2 and HTR2A polymorphisms in treatment-resistant schizophrenia: a comparative analysis with other treatment-resistant mental disorders and the healthy state.Semantic proximity Read ↗

Genetic polymorphism and neuroanatomical changes in schizophrenia.Semantic proximity Read ↗

Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.Semantic proximity Read ↗

[Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].Semantic proximity Read ↗

Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment.Semantic proximity Read ↗

Genetic Variations in the Dopaminergic Signaling Pathways and Their Implications for Antipsychotics Pharmacogenetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.